An Inconvenient Study bannerAn Inconvenient Study banner
An Inconvenient StudyAn Inconvenient Study

An Inconvenient Study

Unknown@aninconvenientstudy  •  Joined September 9, 2025

Live
Sub 11.2K  |  View 466K  |  Video 2
#1,335,964
#2,105,807

At a glance

Subscribers

Last 28 days

11.2K

+300 (+2.8%)

Views

Last 28 days

466K

+15.4K (+3.4%)

Videos

Last 28 days

2

— No change

Charts

Subscribers, views & videos over time

Tap on chart to see values
Loading chart...

Subscribers gained (weekly) · 6 mo

Loading chart...

Views gained (weekly) · 6 mo

Loading chart...

Subs milestone changes (up to 30)

Loading chart...

Views milestone changes (up to 30)

Loading chart...

Engagement

Avg. views per video

233K

Total views ÷ total videos

Views per subscriber

41×

Total views ÷ subscribers

Subs per video

5.61K

Subscribers ÷ total videos

Revenue estimate

Details →

Total (all-time): $326 – $932

Daily avg.: $0 – $1

Weekly avg.: $3 – $8

Last 28 days: $11 – $31

Based on estimated $0.7–$2 CPM.

Analytics tables

Analytics Table:An Inconvenient Study

Date
subscribers
views
videos
Jun 1, 2026
Jun 1
Mon
11.2K
+100
465K
+2.04K
2
--
May 25, 2026
May 25
Mon
11.1K
--
463K
+3.49K
2
--
May 18, 2026
May 18
Mon
11.1K
+200
460K
+8.62K
2
--
May 5, 2026
May 5
Tue
10.9K
--
451K
+3.55K
2
--
May 2, 2026
May 2
Sat
10.9K
--
447K
--
2
--

Subscribers gained (weekly)

WeekSubscribers gainedChange vs prev
May 5, 2026
0
--
May 18, 2026
200
+200
May 25, 2026
0
-200
Jun 1, 2026
100
+100

Views gained (weekly)

WeekViews gainedChange vs prev
May 2, 2026
915
--
May 5, 2026
3.55K
+2.63K
May 18, 2026
8.62K
+5.07K
May 25, 2026
3.49K
-5.13K
Jun 1, 2026
2.04K
-1.44K

About

THIS COULD CHANGE EVERYTHING In 2016, journalist Del Bigtree issued a challenge to the head of infectious disease at one of the most prestigious medical institutions in the world: conduct the most thorough vaxxed vs. unvaxxed study that has ever been done. The expert took up the challenge and ran the study to prove D…

Joined
September 9, 2025

More features coming

We're working on new analytics and tools. Stay tuned.